Annual Drug Patent Expirations for TYRVAYA
Tyrvaya is a drug marketed by Oyster Point Pharma and is included in one NDA. There are five patents protecting this drug.
This drug has twenty-two patent family members in sixteen countries.
The generic ingredient in TYRVAYA is varenicline tartrate. Additional details are available on the varenicline tartrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com